Looking for Kinetico Water Systems? Click Here!

Precision Medicine Practice

The Precision Medicine practice at Kineticos helps diagnostic companies— including labs and tools companies—maximize their commercial potential at the corporate and product levels while ensuring companies operate in an efficient manner.

The Precision Medicine practice at Kineticos supports clients across three service areas including:

Corporate Strategy and Development

  • Market, Competitor, Customer Assessments
  • Go-to-Market Strategy
  • Mergers and Acquisitions
  • Licensing and Acquisitions

Technology and Innovation

  • Technology Assessment
  • R&D Innovation Strategy
  • Co-Development Models

Click the Tabs Below for Precision Medicine Practice Case Studies, White Papers and Articles, and Blog


Case Studies
  • Market Opportunity Assessment

    Situation: An innovative preclinical CRO with multiple disruptive service offerings retained Kineticos to conduct an evaluation of each of their


    Read this Case Study

  • 503B Compounding Pharmacy Market Assessment

    Situation: A global biopharma company was interested in a comprehensive evaluation of the 503B compounding pharmacy market. The client was


    Read this Case Study

  • Primary Research Study

    Kineticos conducted primary research via KOLs and an online survey to give our client qualitative and quantitative data to support


    Read this Case Study

  • Contract Development and Manufacturing Due Diligence

    Challenge: An international private equity firm was looking at acquiring a Contract Development and Manufacturing Organization and needed to understand


    Read this Case Study

  • Go-to-Market Strategy and Tactical Deployment Plan

    Situation: A privately held emerging biotech company, with an innovative cancer detection test, retained Kineticos to assist them in effectively


    Read this Case Study

  • Voice of Customer Study

    Situation: A joint venture between two European companies was looking to maximize the commercial potential of its automated plate reader


    Read this Case Study

  • The Role of Confirmation Bias in Decision Making

    Written by Abe Maingi, VP of Precision Medicine, Kineticos Confirmation bias is our tendency to search for and favor all


    Read this Article

  • Are we Manufacturing the right T-Cells And a Look at the Future of Oncology Precision Medicine

    The final part of the discussion between Kineticos’ Operating Executive, Steve Buckanavage and Precision Biosciences’ CMO, Christopher Heery M.D., covers


    Read this Article

  • Is Precision Medicine in Oncology Narrowing Patient Population Too Much?

    Kineticos’ Operating Executive Steve Buckanavage, continues his discussion with Christopher Heery, M.D., CMO at Precision Biosciences as they tackle the


    Read this Article

  • Can We Create Companion Diagnostics In Oncology With What We Know About Biomarkers?

    As we continue our discussion between Steve Buckanavage, Kineticos’ Operating Executive and Christopher Heery, M.D., CMO at Precision Biosciences, we


    Read this Article

  • Are Checkpoint Inhibitors Impacting How We Cure Disease?

    Throughout September and October, we have been discussing Precision Medicine and it’s impact on various segments of the life sciences.


    Read this Article

  • Is Precision Medicine Impacting Innovation in Pharma?

    Shailesh and Alan finish their discussion with how there were speculation that precision medicine would reduce innovation in pharma. See


    Read this Article

  • How Metrics Can Help Identify and Solve Operational Challenges

    Article Preview As the sophistication of operational practices across life sciences increases; unfortunately, so do the difficulty and complexity of


    Read this Blog Post

  • Growth by Acquisition in Life Sciences: Do You Have a Plan?

    Article Preview As the life sciences landscape continually changes, growth by acquisition has become increasingly common. Recent deals, such as


    Read this Blog Post

  • Next Generation Sequencing: Using Technology to Develop Mutually-Beneficial Partnerships

    Article Preview Arup Laboratories announced it will begin offering next-generation sequencing (NGS) based high resolution Human Leukocyte Antigen (HLA) genotyping


    Read this Blog Post

  • Role of Companion Diagnostics in Immuno-oncology Race Unfolding

    Article Preview Important oncology events, including ASCO and ESMO, have recently displayed the fruits of the huge investment drug companies


    Read this Blog Post

  • Merck KGaA Announces Acquisition of Sigma-Aldrich, Increasing Lab Supply Division Growth

    Article Preview Germany’s Merck KGaA has announced the acquisition of Sigma-Aldrich Corporation, a global life sciences tools (LST) firm, based


    Read this Blog Post

  • Outsourcing as Opportunity

    Article Preview An article published in FiercePharma discussed the top 10 largest pharma layoffs in 2013. Whenever layoffs are announced


    Read this Blog Post

Subscribe to our internal think tank, Kineticos Research Institute